Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.56 USD
+0.07 (4.70%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.56 0.00 (0.00%) 6:38 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Brokerage Reports
Adicet Bio, Inc. [ACET]
Reports for Purchase
Showing records 41 - 60 ( 98 total )
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; ADI-001 Update At ASH; R&D Day Recap
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
3Q22 Results; Updated ADI-001 Data at ASH; R&D Webcast Event on November 10, 2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
ASH 2022 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Updated Data For Phase 1 Trial of ADI-001 in NHL Included in ASH Abstract
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Relevant Abstracts at SITC 2022
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 Results; Additional Phase 1 ADI-001 NHL Clinical Update Expected in 2H22
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
ADI-001 at ASCO: Profile Continues to Look Impressive
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Updated ADI-001 Data Presented at ASCO 2022 Annual Meeting
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
ASCO Abstract Released; Updated Data for ADI-001 in r/r NHL to be Presented at ASCO
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E